<DOC>
	<DOCNO>NCT02405598</DOCNO>
	<brief_summary>evaluate beta 2-adrenergic agonist adjuvant effect patient infantile-onset Pompe disease enzyme replacement therapy</brief_summary>
	<brief_title>Evaluation Salbutamol Adjuvant Therapy Pompe Disease</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>1 . Confirm diagnosis Pompe disease 2. age 2 year 3. least 1 year regular recombinant human acid alpha glucosidase , dosage/frequency change recent 3 month 4 . Provide inform consent 1. chronic heart disease arrhythmia , cardiomyopathy , cardiac infarction 2. history seizure 3. history diabetes mellitus 4. history hyperthyroidism 5. hypokalemia 6. pregnant 7. allergy Î²agonists 8. medication include diuretic , digoxin , betablockers , etc</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>